drugset / Trial / NCT02205489
Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA
NaSingle-groupOpen-labelTreatment
Summary
Primary Objective: To assess the distribution of IARs by severity grade when LEMTRADA is administered to RRMS patients who will be medicated according to specified algorithm designed to manage infusion associated reactions.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alemtuzumab | Monoclonal antibody | — | Intravenous |
| Background | Acetaminophen | Small molecule | — | Oral |
| Background | Acyclovir | Small molecule | — | Oral |
| Background | Cetirizine | Other / unclassified | — | Oral |
| Background | Esomeprazole | Small molecule | — | Oral |
| Background | Ibuprofen | Small molecule | — | Oral |
| Background | Methylprednisolone | Other / unclassified | — | Oral |
| Background | Ranitidine | Unknown | — | Oral |